New technology uses a smartphone to analyze heart movement, detect heart failure

The new technology, which was created at the University of Turku and developed by the company CardioSignal, uses a smartphone to analyze heart movement and detect heart failure. The study involved five organizations from Finland and the United States.

Heart failure is a condition affecting tens of millions of people worldwide, in which the heart is unable to perform its normal function of pumping blood to the body. It is a serious condition that develops as a result of a number of cardiovascular diseases and its symptoms may require repeated hospitalization.

Heart failure is challenging to diagnose because its symptoms, such as shortness of breath, abnormal fatigue on exertion, and swelling, can be caused by a number of conditions. There is no simple test available to detect it and diagnostics relies on an examination by a doctor, blood tests, and sophisticated imaging, such as an ultrasound scan of the heart.

Gyrocardiography is a non-invasive technique for measuring cardiac vibrations on the chest. The smartphone's built-in motion sensors can detect and record these vibrations, including those that doctors cannot hear with a stethoscope. The method has been developed over the last 10 years by researchers at the University of Turku and CardioSignal.

The researchers' latest study on using smartphone motion sensors to detect heart failure was carried out at the Turku and Helsinki University Hospitals in Finland and Stanford University Hospital in the US. Approximately 1,000 people took part in the study, of whom around 200 were patients suffering from heart failure. The study compared the data provided by the motion sensors in the heart failure patients and patients without heart disease.

"The results we obtained with this new method are promising and may in the future make it easier to detect heart failure," says Cardiologist Antti Saraste, one of the two main authors of the research article and the Professor of Cardiovascular Medicine at the University of Turku, Finland.

Precise detection uncovers heart failure

The researchers found that heart failure is associated with typical changes in the motion sensor data collected by a smartphone. On the basis of this data, the researchers were able to identify the majority of patients with heart failure.

The analysis of the movements detected by the gyroscope and accelerometer is so accurate that in the future it could provide healthcare professionals with a quick and easy way to detect heart failure.

Primary healthcare has very limited tools for detecting heart failure. We can create completely new treatment options for remote monitoring of at-risk groups and for monitoring already diagnosed patients after hospitalization."

Juuso Blomster, Cardiologist, CardioSignal's founding member and CEO

Consistent with several European countries, heart failure affects around 1-2% of the population in Finland, but it is much more common in older adults, affecting around one in ten people aged 70. Detecting heart failure is important as effective treatment can help to alleviate its symptoms. Accurate diagnosis and timely access to treatment can also reduce healthcare costs, which are driven up by emergency room visits and hospital stays, especially during exacerbations.

The joint research projects between CardioSignal and the University of Turku aim to promote people's health and reduce healthcare costs through innovation, improved disease diagnostics, and prevention of serious complications.

Source:
Journal reference:

Haddad, F., et al. (2024). Smartphone-Based Recognition of Heart Failure by Means of Microelectromechanical Sensors. JACC. Heart Failure. doi.org/10.1016/j.jchf.2024.01.022.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis